This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Silverback Therapeutics Future Growth
Future criteria checks 0/6
Key information
136.7%
Earnings growth rate
120.7%
EPS growth rate
| Biotechs earnings growth | 23.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
Recent updates
Here's Why We're Not Too Worried About Silverback Therapeutics' (NASDAQ:SBTX) Cash Burn Situation
Jul 13
Companies Like Silverback Therapeutics (NASDAQ:SBTX) Are In A Position To Invest In Growth
Aug 30Silverback Therapeutics (NASDAQ:SBTX) Is In A Good Position To Deliver On Growth Plans
May 15Have Insiders Been Buying Silverback Therapeutics, Inc. (NASDAQ:SBTX) Shares This Year?
Mar 04Silverback Therapeutics is a buy at Goldman Sachs on unique therapy platform
Dec 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | N/A | N/A | N/A | -37 | 1 |
| 12/31/2023 | N/A | 0 | N/A | -34 | 1 |
| 12/31/2022 | N/A | -58 | N/A | -55 | 1 |
| 9/30/2022 | N/A | -86 | -74 | -73 | N/A |
| 6/30/2022 | N/A | -91 | -77 | -75 | N/A |
| 3/31/2022 | N/A | -96 | -76 | -74 | N/A |
| 12/31/2021 | N/A | -90 | -68 | -67 | N/A |
| 9/30/2021 | N/A | -79 | -58 | -57 | N/A |
| 6/30/2021 | N/A | -65 | -46 | -44 | N/A |
| 3/31/2021 | N/A | -47 | -37 | -36 | N/A |
| 12/31/2020 | N/A | -33 | -32 | -31 | N/A |
| 9/30/2020 | N/A | -27 | -27 | -26 | N/A |
| 12/31/2019 | N/A | -24 | -19 | -19 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SBTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SBTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SBTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if SBTX's revenue is forecast to grow faster than the US market.
High Growth Revenue: SBTX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SBTX's Return on Equity is forecast to be high in 3 years time